Effects of second messengers on the permeability and morphology of eel rete capillaries.
The effects of second-messenger concentration changes on capillary diffusion capacity (permeability-surface area product [PS]) to cellular and paracellular tracers and on capillary ultrastructure were studied during countercurrent perfusion of the rete of the eel swim bladder. Cyclic nucleotide effects were investigated with isoproterenol, forskolin, and dibutyryl cAMP. Isoproterenol (5 x 10(-6) mol/L) did not modify water and solute permeability or capillary structure. Forskolin (10(-4) mol/L) immediately raised the concentrations of cAMP in the rete and produced interstitial edema but did not change permeability. The addition of dibutyryl cAMP (10(-6) mol/L) to the perfusate had rapid effects: it reduced the PS of [3H]water and oxygen and increased the PS of [125I]albumin, [14C]sucrose, and 22Na. No structural changes were observed. Phosphoinositide effects were studied with 1,2-dioctanoyl-sn-glycerol (DG) and phorbol 12-myristate 13-acetate (PMA). DG (10(-5) mol/L) had no effect on the permeability of the rete to water and solutes, while inducing cell membrane vacuolization. PMA (10(-5) mol/L) progressively reduced the PS of [3H]water. In contrast, PS values of [125I]albumin, [14C]sucrose, and 22Na rose gradually. Membrane vacuoles bulging into the lumen and in the cytoplasm were a common feature. The Ca2+ effect was investigated with the Ca2+ ionophore A23187. At 5 x 10(-6) mol/L, unsteady permeability changes and extensive cytolysis were observed. At 5 x 10(-7) mol/L, the PS of [125I]albumin, [14C]sucrose, and 22Na rapidly increased. The PS values for water were not modified. No structural changes were identified.(ABSTRACT TRUNCATED AT 250 WORDS)
Rasio
E A
EA
Department of Medicine, Hôpital Notre-Dame, Montreal, Quebec, Canada.
Bendayan
M
M
Goresky
C A
CA
D000418:Albumins / Q000378:metabolism; D000818:Animals; D003994:Bucladesine / Q000494:pharmacology; D000001:Calcimycin / Q000494:pharmacology; D002118:Calcium / Q000502:physiology*; D002196:Capillaries / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure*; D002199:Capillary Permeability / Q000187:drug effects; D005576:Colforsin / Q000494:pharmacology; D004075:Diglycerides / Q000494:pharmacology; D004524:Eels; D007545:Isoproterenol / Q000494:pharmacology; D008854:Microscopy, Electron; D009712:Nucleotides, Cyclic / Q000502:physiology*; D010716:Phosphatidylinositols / Q000502:physiology*; D015290:Second Messenger Systems; D012964:Sodium / Q000378:metabolism; D013395:Sucrose / Q000378:metabolism; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D000418:Albumins; D004075:Diglycerides; D009712:Nucleotides, Cyclic; D010716:Phosphatidylinositols; C044295:1,2-dioctanoylglycerol; D005576:Colforsin; D000001:Calcimycin; D013395:Sucrose; D003994:Bucladesine; D012964:Sodium; D007545:Isoproterenol; D013755:Tetradecanoylphorbol Acetate; D002118:Calcium